Acadia Healthcare Company, Inc.'s next confirmed earnings release is scheduled for March 1, 2027.
| Earnings Date | 3/1/2027 |
As of September 30, 2026, Acadia Healthcare Company, Inc. has 90.91M shares outstanding.
| Shares Outstanding | 90.91M |
As of September 30, 2026, Acadia Healthcare Company, Inc. maintains a current ratio of 1.60, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 111.20, indicating elevated leverage, while an interest coverage ratio of -4.79 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.60 |
| Quick Ratio | 1.31 |
| Debt / Equity | 111.20 |
| Debt / EBITDA | -3.45 |
| Interest Coverage | -4.79 |
Over the twelve months ended September 30, 2026, Acadia Healthcare Company, Inc. posted a negative return on equity (ROE) of -43.87, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -18.85, reflecting losses generated across the asset base. The company generates approximately 120,395.45 in revenue per employee across its workforce of 25,000.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 19.52 indicates how many times Acadia Healthcare Company, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | -43.87 |
| Return on Assets (ROA) | -18.85 |
| Revenue Per Employee | 120,395.45 |
| Employee Count | 25,000.00 |
| Inventory Turnover | 19.52 |
Over the twelve months ended September 30, 2026, Acadia Healthcare Company, Inc. recorded 36.98M in income tax expense. The company reported a pretax loss of -952.85M and -995.23M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | 36.98M |
Over the twelve months ended September 30, 2026, Acadia Healthcare Company, Inc. generated 3.01B in revenue and converted that into -995.23M in net income, yielding earnings per share of -10.86. EBITDA reached -641.00M, while operating income came in at 294.09M.
| Revenue | 3.01B |
| Gross Profit | 2.90B |
| Operating Income | 294.09M |
| Pretax Income | -952.85M |
| Net Income | -995.23M |
| EBITDA | -641.00M |
| EBIT | -818.99M |
| Earnings Per Share (EPS) | -10.86 |
As of September 30, 2026, Acadia Healthcare Company, Inc. holds 144.09M in cash and equivalents against 2.21B in total debt, resulting in a net debt position of 1.93B. Total book value stands at 1.78B, with working capital of 290.53M providing operational flexibility.
| Cash & Cash Equivalents | 144.09M |
| Total Debt | 2.21B |
| Net Debt | 1.93B |
| Equity (Book Value) | 1.78B |
| Book Value Per Share | 19.63 |
| Working Capital | 290.53M |
Acadia Healthcare Company, Inc. produced 207.51M in operating cash flow over the twelve months ended September 30, 2026.
| Operating Cash Flow | 207.51M |
| Free Cash Flow | 207.51M |
| FCF Per Share | 2.29 |
Over the twelve months ended September 30, 2026, Acadia Healthcare Company, Inc. posted a gross margin of 96.43, reflecting its pricing power and cost economics. The operating margin of 9.77 and net profit margin of -33.07 provide insight into operational efficiency.
| Gross Margin | 96.43 |
| Operating Margin | 9.77 |
| Pretax Margin | -31.66 |
| Profit Margin | -33.07 |
| EBITDA Margin | -21.30 |
Acadia Healthcare Company, Inc.'s most recent stock split took place on November 1, 2011 with a 4:1 split ratio.
| Last Split Date | 11/1/2011 |
| Split Ratio | 4:1 |